Image courtesy of Pixabay
Big data and AI offer massive opportunities to the pharmaceutical industry — in theory. In reality, many companies are struggling to realize the potential of these tools. Some organizations have been hesitant or resistant to leveraging the technologies. Others may have attempted to embrace them early on but are now beginning their second or third incarnations of “digital transformation,” likely with some layoffs along the way.
Why the difficulty? Digital transformation is, of course, a massive undertaking — requiring enterprise-wide coordination and a clear, focused vision. In the real world, organizations have struggled with defining a focus for their AI efforts and sustaining the investments necessary to reach them. It’s easy to get excited about the prospect of using AI to solve everything under the sun, but more often, successes are coming when teams stay focus…